Last reviewed · How we verify

NCT07332728

Diaphragmatic Excursion Changes and Postoperative Oxygenation After Laparoscopic Cholecystectomy

Not yet recruiting Last updated 14 January 2026
What this trial tests

trial testing Standard perioperative care with observational diaphragm ultrasonography in Perioperative Diaphragmatic Excursion in 62 participants. Not yet recruiting.

Timeline
15 January 2026
Primary endpoint
15 April 2026
30 April 2026

Quick facts

Lead sponsorIstinye University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment62
Start date15 January 2026
Primary completion15 April 2026
Estimated completion30 April 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istinye University

Who can join

Adults 18 to 75, any sex, with Perioperative Diaphragmatic Excursion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic cholecystectomy and the associated pneumoperitoneum can impair diaphragmatic mechanics and reduce postoperative oxygenation. This prospective observational study aims to evaluate perioperative changes in diaphragmatic excursion measured by ultrasonography and to investigate their association with early postoperative oxygenation parameters and hypoxemia. By correlating diaphragmatic excursion changes with SpO₂/FiO₂ and the ROX index, the study seeks to clarify the physiological contribution of diaphragmatic dysfunction to postoperative hypoxemia in patients undergoing laparoscopic cholecystectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Istinye University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07332728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing